FDA Sets Priorities for 2016: What Does It Mean for Medical Devices?

March 16, 2016 / by MedTech Momentum posted in Big Data, biocompatibility, FDA, medical devices, Regulatory

0 Comments

It’s the year of Big Data, and FDA has slated several priorities for fiscal year 2016 to improve regulatory science and introduce revised data quality standards.
From leveraging Big Data for regulatory decision making, to enhancing diverse population data for clinical trials and studies, the agency’s 2016 goals are guided by the medical device industry’s call for increased participation, transparency, and overall quality. What do these changes mean for medical devices?

Subscribe to Email Updates

Lists by Topic

see all

Posts by Topic

See all

Recent Posts